Turmeric Extract Kills Highly Lethal Pancreatic Tumors, Preclinical Study Reveals - If tumeric can do this - imagine what medical cannabis does and can do

Considering that the conventional treatment of advanced stage pancreatic cancer can result in as little as a 1% 5-year survival rate, new preclinical research on a liposomal turmeric extract that inhibits pancreatic tumor growth by 42% is all the more amazing. 

 

A promising new study published in the journal Anticancer Research, a peer-reviewed medical journal published by the International Institute of Anticancer Research, reveals a unique turmeric extract known as liposomal curcumin may provide an ideal chemotherapy alternative in the treatment of highly lethal pancreatic cancers.[1]

Curcumin is the primarly polyphenol in turmeric, and has been the subject of extensive research demonstrating its ability to kill cancer cells, with over 1,500 studies available to view on Greenmedinfo.com relevant to over 100 distinct cancer types, including 24 studies demonstrating its anti-pancreatic cancer properties. [View all the curcumin studies.]

Liposomal curcumin utilizes a successful lipid-based drug delivery system, with some liposomal formulations having already received FDA approval.  Owing to curcumin's low water solubility and subsequent low systemic bioavailability, its encapsulation into liposomes (artificially-prepared vesicle composed of a lipid bilayer) greatly improves its ability to gain entry into the body by passing through the 'glucoronidation barrier' in the liver.

Continue reading: http://www.greenmedinfo.com/blog/curcumin-extract-kills-highly-lethal-pancreatic-tumors-preclinical-study-revealed